Skip to content

    Intellia Therapeutics (NTLA) stock price & financials

    View NTLA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+12.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $9.11M
    $12.87M
    $16.63M
    $14.24M
    $13.78M
    +51.3%
    $23.02M
    +78.8%
    $15.05M
    -9.5%
    $7.66M
    -46.2%
    Strengthening
    Operating Profit
    -$144.77M
    -$136.45M
    -$120.81M
    -$110.00M
    -$111.48M
    +23.0%
    -$98.71M
    +27.7%
    -$100.53M
    +16.8%
    -$112.76M
    -2.5%
    Strengthening
    Net Profit
    -$135.71M
    -$128.90M
    -$114.33M
    -$101.25M
    -$101.32M
    +25.3%
    -$95.79M
    +25.7%
    -$96.23M
    +15.8%
    -$106.63M
    -5.3%
    Strengthening
    EPS
    $-1.34
    $-1.10
    $-0.98
    $-0.92
    +31.3%
    $-0.81
    +26.4%
    $-0.80
    +18.4%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -1589.0%
    -1059.9%
    -726.6%
    -772.2%
    -808.9%
    +49.1%
    -428.9%
    +59.5%
    -668.1%
    +8.1%
    -1472.3%
    -90.7%
    Weakening
    Tax
    ReturnsROIC
    4.3%
    4.1%
    3.7%
    3.2%
    3.2%
    -25.3%
    3.1%
    -25.7%
    3.1%
    -15.8%
    3.4%
    +5.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$58.86M$57.23M$160.02M$123.41M$523.51M$226.75M$189.18M$155.46M$106.13M
    Short-Term Investments$255.20M$222.50M$437.35M$625.28M$669.12M$685.48M$412.33M$294.42M$331.63M
    Total Current Assets$324.98M$289.48M$616.52M$769.30M$1.22B$998.33M$639.86M$527.71M$527.83M
    Net PP&E$17.06M$37.13M$55.06M$100.11M$161.00M$148.13M$246.67M$123.63M$101.01M
    Goodwill
    Intangibles
    Total Assets$347.31M$334.28M$676.32M$1.29B$1.52B$1.30B$1.19B$842.13M$857.16M
    LiabilitiesTotal Current Liabilities$40.57M$35.63M$64.25M$125.83M$126.55M$115.21M$110.85M$103.88M$79.39M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$12.63M$33.61M$64.91M$114.02M$96.75M$189.95M$66.85M$50.07M
    Total Liabilities$69.39M$64.40M$149.25M$254.22M$284.53M$250.81M$319.06M$170.73M$129.46M
    EquityCommon Stock & APIC$5.0K$5.0K$7.0K$7.0K$9.0K$9.0K$10.0K$12.0K$14.0K
    Retained Earnings-$201.03M-$300.88M-$435.11M-$703.00M-$1.18B-$1.66B-$2.18B-$2.59B-$2.79B
    Total Equity$277.92M$269.88M$527.07M$1.04B$1.24B$1.05B$871.96M$671.39M$727.71M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$61.26M-$103.24M-$49.91M-$225.03M-$333.29M-$394.09M-$348.88M-$394.74M-$346.64M
    Cash from Investing-$260.78M$25.18M-$214.49M-$550.78M$160.31M-$31.35M$125.57M$228.03M-$48.47M
    Cash from Financing$40.22M$76.43M$371.78M$736.69M$582.96M$130.32M$185.75M$131.49M$346.52M
    SummaryCapital Expenditure-$6.36M-$6.79M-$3.58M-$12.76M-$13.56M-$13.98M-$5.78M-$1.13M-$2.04M
    Free Cash Flow-$67.61M-$110.03M-$53.50M-$237.79M-$346.85M-$408.07M-$354.66M-$395.87M-$348.69M
    FCF Margin-222.2%-255.3%-92.2%-719.4%-665.5%-1124.9%-612.8%-585.0%-586.0%

    Ratios